Asia Pacific Pharmaceutical Isolator Market Segments and Growth by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Asia Pacific Pharmaceutical Isolator Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Open Isolator and Closed Isolator), Pressure (Positive Pressure and Negative Pressure), Configuration (Floor Standing, Modular, Mobile, and Compact), Application (Aseptic Isolators, Containment Isolators, Sampling and Weighing Isolators, Fluid Dispensing Isolators, and Others), and End User (Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Laboratories, and Others)

  • Report Date : Nov 2021
  • Report Code : TIPRE00025883
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 160

The APAC pharmaceutical isolator market is expected to grow from US$ 1,060.82 million in 2021 to US$ 1,975.83 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2021 to 2028.



China, India, Japan, South Korea, and Australia are major economies in APAC. Burgeoning adoption of automation in pharmaceutical isolator is expected to fuel the market growth. In the pharmaceutical industry. automation of aseptic procedures, with the help of dedicated workstations and system software, has lowered manual interference in manufacturing processes, increased efficiency, and enabled researchers to concentrate on important tasks and avoid human errors. The increased adoption of automated pharmaceutical isolators can also be attributed to factors such as maintaining stringent regulatory compliance, increasing efficiency and productivity, and driving the safety and integrity of pharmaceutical products. The advancement of automation, including robotics, is one area of progress for aseptic fill-finish processes. Recent emerging technologies in aseptic processing, such as advanced isolators, robotics, and increased automation, are expected to change the industry and markedly reduced contamination risks for sterile products. Conventional isolator systems routinely require many operators at a time when regulators have long stated the need for aseptic filling systems to use robotics and reduce human interaction in drug manufacturing. Gloveless isolator technology for biopharmaceutical processes is getting traction in the industry. Future trends in technology are making isolators increasingly attractive for aseptic operations. Automated isolators are a perfect fit for parenteral solution products that can ensure the highest level of aseptic conditions. Therefore, growing use of automation is expected to fuel the APAC market growth. 

In case of COVID-19, APAC is highly affected specially India. The APAC biopharmaceutical industry has been disturbed for few months of 2020 during the outbreak of the COVID-19 pandemic. However, with the rising demand for products to treat the COVID-19 infection, the biopharmaceutical, and pharmaceutical companies in the countries such as India and China have increased their production of APIs as the countries are the largest exporters to western companies. For instance, Wockhardt Ltd is in talks with the Indian government to offer its sterile development facility for the covid-19 vaccines that will be developed in the country, as well as with some firms whose vaccines are currently in phase I/II trials globally. Moreover, on 07 May 2020, Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services with sites in Belgium, United States, Japan, and India, announced it has entered into a manufacturing services agreement with CytoDyn Inc., a late-stage biotechnology company, for the supply of the investigational new drug, leronlimab (PRO 140), which is currently being used in clinical trial protocols for Mild-to-Moderately Ill and Severely Ill COVID-19 patients. The countries are experiencing growth in biologics production also; there is growth in the contract manufacturing for biopharmaceutical and pharmaceutical products. For instance, in January 2020, STA Pharmaceutical Co., Ltd. (WuXi AppTec) has expanded its oligonucleotide API manufacturing in China. Similarly, companies have engaged in the production of vaccines and have sent them to clinical trials. For instance, in Japan, Gilead's Remdesivier and Fujifilm's antiviral Avigan are in Phase III clinical trials. Thus, with the growing production by the biopharmaceutical industry, the pharmaceutical isolators market is likely to have vital growth opportunities in the following years.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC pharmaceutical isolator market. The APAC pharmaceutical isolator market is expected to grow at a good CAGR during the forecast period.
APAC pharmaceutical isolator market

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

APAC Pharmaceutical Isolator Market Segmentation      

APAC Pharmaceutical Isolator Market – By Type

  • Open Isolators
  • Closed Isolators

APAC Pharmaceutical Isolator Market – By Pressure

  • Positive Pressure
  • Negative Pressure

APAC Pharmaceutical Isolator Market – By Configuration

  • Floor Standing
  • Modular
  • Compact
  • Mobile

APAC Pharmaceutical Isolator Market – By Application

  • Aseptic
  • Sampling & Weighing
  • Fluid Dispensing
  • Containment    
  • Others

APAC Pharmaceutical Isolator Market – By End User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals
  • Research and Academic Laboratories
  • Other

APAC Pharmaceutical Isolator Market, by Country

  • China
  • Japan
  • India
  • Australia 
  • South Korea
  • Rest of APAC 

APAC Pharmaceutical Isolator Market -Companies Mentioned

  • Azbil Telstar
  • Bioquell (Ecolab Solution)
  • Comecer
  • Fedegari Autoclavi S.p.A.
  • Gelman Singapore
  • Getinge AB
  • Hosokawa Micron Group
  • Nuaire Inc.
  • Schematic Engineering Industries

Asia Pacific Pharmaceutical Isolator Report Scope

Report Attribute Details
Market size in 2021 US$ 1,060.82 Million
Market Size by 2028 US$ 1,975.83 Million
Global CAGR (2021 - 2028) 9.3%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Open Isolator and Closed Isolator
By Pressure
  • Positive Pressure and Negative Pressure
By Configuration
  • Floor Standing
  • Modular
  • Mobile
  • Compact
By Application
  • Aseptic Isolators
  • Containment Isolators
  • Sampling and Weighing Isolators
  • Fluid Dispensing Isolators
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Azbil Telstar
  • Bioquell (Ecolab Solution)
  • Comecer
  • Fedegari Autoclavi S.p.A.
  • Gelman Singapore
  • Getinge AB
  • Hosokawa Micron Group
  • Nuaire Inc.
  • Schematic Engineering Industries
  • Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    1. Azbil Telstar
    2. Bioquell (Ecolab Solution)
    3. Comecer
    4. Fedegari Autoclavi S.p.A.
    5. Gelman Singapore
    6. Getinge AB
    7. Hosokawa Micron Group
    8. Nuaire Inc.
    9. Schematic Engineering Industries
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo